Home » Topics » Regulatory

Regulatory
RSS

ML Laboratories granted second license from U.K. authorities for its dry powder inhaler

Nov. 17, 1998

Nolvadex now available for breast cancer prevention

Nov. 17, 1998

New oral ultrasound contrast agent approved by FDA

Nov. 17, 1998

Improved dosage form of selegiline now on the U.K. market

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

FDA approves Actiq for treatment of breakthrough cancer pain

Nov. 6, 1998

First Neoral equivalent cleared by FDA

Nov. 4, 1998

U.S. grants first approval for GelTex's novel phosphate-binding polymer therapeutic

Nov. 3, 1998

Genvir is as effective as Zovirax in genital herpes, with improved dosing

Nov. 3, 1998

Positive CPMP opinion issued for Betaseron in new indication

Nov. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...